Theralase Technologies (CVE:TLT – Get Rating) released its quarterly earnings results on Tuesday. The company reported C($0.01) earnings per share for the quarter, reports. The business had revenue of C$0.21 million for the quarter. Theralase Technologies Price Performance Shares of TLT remained flat at C$0.25 during mid-day trading on Friday. 13,701 shares of the stock […]
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.